Helping You Build Wealth With Honest Research
Since 1996. Read On...

The Best Asset Allocation for Your Equity Portfolio

SOLARA ACTIVE PHARMA SCIENCES Gains 5%; BSE HEALTHCARE Index Down 0.5%
Tue, 9 Dec 10:39

SOLARA ACTIVE PHARMA SCIENCES Gains 5%; BSE HEALTHCARE Index Down 0.5%Image source: Ivcandy/www.istockphoto.com

SOLARA ACTIVE PHARMA SCIENCES share price has zoomed 5% and is presently trading at Rs 576.3.

Meanwhile, the BSE HEALTHCARE index is at 43,524.3 (down 0.5%).

Among the top gainers in the BSE HEALTHCARE index today are ERIS LIFESCIENCES (up 4.8%) and GRANULES INDIA (up 2.0%).

IPCA Labs (down 2.7%) and DR. LAL PATHLABS (down 2.0%) are among the top losers today.

Over the last one year, SOLARA ACTIVE PHARMA SCIENCES has moved down from Rs 802.5 to Rs 576.3, registering a loss of Rs 226.2 (down 28.2%).

On the other hand, the BSE HEALTHCARE index has moved down from 44,543.8 to 43,524.3, registering a loss of 2.3% during the last 12 months.

The top losers among the BSE HEALTHCARE index stocks during this same period were COHANCE LIFESCIENCES (down 59.4%), Natco Pharma (down 37.9%) and POLY MEDICURE (down 35.9%).

Discover: Where the opportunities are emerging for the next 3-5 years

What About the Benchmark Indices?

The BSE Sensex is at 84,614.7 (down 0.6%).

The top losers among the BSE Sensex today are Asian Paints (down 3.5%) and TCS (down 1.6%). The most traded stocks in the BSE Sensex are Eternal Ltd and Reliance Ind..

In the meantime, NSE Nifty is at 25,796.6 (down 0.6%). Asian Paints and Hero Motocorp are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 81,765.9 to 84,614.7, registering a gain of 2,848.8 points (up 3.5%).

SOLARA ACTIVE PHARMA SCIENCES Financial Update...

SOLARA ACTIVE PHARMA SCIENCES net profit fell 226.1% YoY to Rs -101 million for the quarter ended September 2025, compared to a profit of Rs 80 million a year ago. Net sales declined 9.6% to Rs 3,135 million during the period as against Rs 3,470 million in July-September 2024.

For the year ended March 2025, SOLARA ACTIVE PHARMA SCIENCES reported 100.1% increase in net profit to Rs 5 million compared to net loss of Rs 5,670 million during FY24. Revenue of the company fell 0.4% to Rs 12,838 million during FY25.

The current Price to earnings ratio of SOLARA ACTIVE PHARMA SCIENCES, based on rolling 12 month earnings, stands at 433.1.


Equitymaster requests your view! Post a comment on "SOLARA ACTIVE PHARMA SCIENCES Gains 5%; BSE HEALTHCARE Index Down 0.5%". Click here!